Finance

Lists
Why is CUE down 5,46%?
Dive Deeper
CUE:NASDAQ
Cue Biopharma Inc
4,50 $
-5,46%
(-0,26) 1D
4,24 $
-5,76% (-0,26)
After hours
Closed: 19 նոյ, 16:00:01 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CUE...
Open
4,48 $
High
5,16 $
Low
3,85 $
Mkt. cap
37,62 մլն
Avg. vol.
736,68 հզր
Volume
2,09 մլն
52-wk high
45,50 $
52-wk low
2,83 $
EPS
-26,99 $
Beta
2,79
Shares outstanding
8,36 մլն
No. of employees
29
Open
4,48 $
High
5,16 $
Low
3,85 $
Mkt. cap
37,62 մլն
Avg. vol.
736,68 հզր
Volume
2,09 մլն
52-wk high
45,50 $
52-wk low
2,83 $
EPS
-26,99 $
Beta
2,79
Shares outstanding
8,36 մլն
No. of employees
29
News stories
From web sources and news partners
About Cue Biopharma Inc
CEO-
Employees29
Founded2014
HeadquartersԲոստոն, Մասսաչուսեթս, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Analyst ratings
Based on 2 analysts giving stock ratings to CUE in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for CUE in the last 3 months.
Highest
Current 4,50 $
25,00 $ (+455,56%)
Average
25,00 $ (+455,56%)
Lowest
25,00 $ (+455,56%)
Analyst
Recommendation
Action
Price target
Projected
Date
Mayank Mamtani
B. Riley Securities
Buy
Maintained
25,00 $
+455,6%
11/18/2026
Dev Prasad
Lucid Capital
Buy
Maintained
-
-
11/18/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
2,15 մլն
21,94 մլն
5,69 մլն
7,88 մլն
Cost of goods sold
4,15 մլն
15,93 մլն
6,40 մլն
48,51 մլն
Cost of revenue
4,15 մլն
15,93 մլն
6,40 մլն
48,51 մլն
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,54 մլն
4,05 մլն
4,65 մլն
47,06 մլն
Operating expense
5,54 մլն
4,05 մլն
4,65 մլն
47,06 մլն
Total operating expenses
9,69 մլն
19,98 մլն
11,05 մլն
95,57 մլն
Operating income
-7,54 մլն
1,96 մլն
-5,36 մլն
-87,70 մլն
Other non operating income
-
-
-
-65,52 մլն
EBT including unusual items
-7,45 մլն
2,08 մլն
-5,18 մլն
-153,07 մլն
EBT excluding unusual items
-7,40 մլն
2,06 մլն
-5,19 մլն
-153,07 մլն
Income tax expense
-
500,00 հզր
-
-
Effective tax rate
-
23,98%
-
-
Other operating expenses
-
-
-
-
Net income
-7,45 մլն
1,58 մլն
-5,18 մլն
-153,07 մլն
Net profit margin
-346,58%
7,22%
-91,07%
-1 943,21%
Earnings per share
-2,10
-
-
-
Interest and investment income
222,00 հզր
158,00 հզր
179,00 հզր
157,00 հզր
Interest expense
-75,00 հզր
-51,00 հզր
-4,00 հզր
-5,00 հզր
Net interest expenses
147,00 հզր
107,00 հզր
175,00 հզր
152,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
-7,46 մլն
2,64 մլն
-4,80 մլն
-87,66 մլն
Gain or loss from assets sale
51,00 հզր
-20,00 հզր
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google Apps